Context
Cyclooxygenases participate in the pathogenesis of atherothrombotic lesions by two opposing mechanisms. Platelet cyclooxygenase-1 (COX-1) participates in the synthesis of thromboxane A 2 (TxA 2 ), a potent vasoconstrictor and platelet activator, and endothelial cyclooxygenase-2 (COX-2) mediates the synthesis of prostacyclin (PGI 2 ), a vasodilator and platelet inhibitor. Nonsteroidal antiinflammatory drugs (NSAIDs) and aspirin exert differential effects on platelet-endothelium interactions that are dependent upon their relative capacity to inhibit COX-1 and COX-2 isoenzymes. Potent and sustained inhibition of COX-1 by low dose aspirin provides efficient anti-thrombotic prophylaxis. Different NSAIDs can induce transient and variable inhibition of COX-1-dependent TxA 2 synthesis, and all NSAIDs and COX-2 selective drugs inhibit COX-2 dependent PGI 2 synthesis, but the clinical relevance of both effects is still unclear. These authors explored the role of TxA2/PGI2 balance in the response to vascular injury using TxA 2 and PGI 2 receptor knockout mice.
Significant findings
Catheter-induced vascular injury was enhanced in mice genetically deficient in the PGI 2 receptor, whereas it was depressed in those mice genetically deficient in the TxA 2 receptor or treated with a TxA 2 receptor antagonist. The augmented response to vascular injury was abolished in mice deficient in both receptors.
Comments
The results of Cheng et al. are consistent with the well known role of TxA 2 in vascular disease and demonstrate a role in counterbalancing TxA 2 platelet activation for PGI 2 synthesized in response to vascular injury. However, the authors' extrapolation regarding the clinical use of NSAIDs versus COX-2 selective inhibitors is not clear because most NSAIDs lack the potent inhibition and anti-platelet effect provided by aspirin. These data in knockout mice remind us of the need to ensure anti-platelet prophylaxis in patients with cardiovascular disease, particularly before using either NSAIDs or COX inhibitors, but further studies on the potential clinical effects of PGI 2 inhibition by both types of drugs are still warranted.
Methods
Carotid-induced injury, histomorphometric analyses.
